Evaluation of Age-Related Skin Changes

July 16, 2019 updated by: Allergan

Evaluation of Age-Related Skin Changes Using Clinical Probe Measurements and Imaging

This trial is a knowledge study utilizing skin measurement probes that are non-invasive instruments, with negligible risks for the subjects. No product will be studied.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Villeurbanne, France, 69100
        • Dermscan-Pharmascan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

100 female subjects will be included, with at least 10 subjects per age decade

Description

Inclusion Criteria:

  • Caucasian subjects with Fitzpatrick skin type II or III.
  • Subject agreeing to complete all study required procedures.
  • Subject having given freely and expressly her informed consent.

Exclusion Criteria:

  • Pregnant or nursing woman or planning a pregnancy during the study.
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
  • Subject in a social or sanitary establishment.
  • Subject participating to another research on human beings or being in an exclusion period for a previous study.
  • Subject who underwent tissue augmentation with dermal fillers including HA, calcium hydroxylapatite, autologous fat, mesotherapy, or other cosmetic procedures (eg, face-lift, laser, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, liposuction of the thigh, or other ablative procedures) in the face or thigh within 12 months before study entry or was planning to undergo any such treatment during the study.
  • Subject who underwent treatment with botulinum toxins in the face or neck within 6 months of study entry or was planning to undergo such treatment during the study.
  • Subject who ever received semi-permanent fillers or permanent facial implants (eg, poly-L-lactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the face or thigh, or was planning to be implanted with any of these products at any time during the study.
  • Subject with current cutaneous inflammatory or infectious processes (eg, acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the face or thigh that could interfere with measurements.
  • Subject having changed, started or stopped any hormonal treatment or any treatment likely to have an impact on skin condition (over-the-counter or prescription, oral or topical, or anti-wrinkle products on the face), within 30 days prior to enrollment or is planning to begin using such products during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
20-29 Years Old
30-39 Years Old
40-49 Years Old
50-59 Years Old
60-69 Years Old
70-79 Years Old

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age-related changes in fine lines on the cheek
Time Frame: 4 Months

Measured using a 5 point photonumeric scale (Allergan Fine Lines scale)

The scale range is 0 to 4, with 0 indicating no fine lines and 4 being the most severe fine lines (greater than 5 superficial lines with crosshatching).

4 Months
Age-related changes in skin hydration on the cheek
Time Frame: 4 Months
Tissue dielectric constant measurement using MoistureMeter D (Delfin Technologies). Tissue dielectric constant is expressed as a unitless value that is directly proportional to the amount of water in the tissue.
4 Months
Age-related changes in skin hydration on the cheek
Time Frame: 4 Months
Tissue dielectric constant measurement using a Corneometer (Courage & Khazaka). Tissue dielectric constant is expressed as a unitless value that is directly proportional to the amount of water in the tissue.
4 Months
Age-related changes in skin barrier function on the cheek
Time Frame: 4 Months
Transepidermal water loss measurement using an AquaFlux AF100 (Biox Systems Ltd)
4 Months
Age-related changes in skin radiance on the cheek
Time Frame: 4 Months
Measurement of light reflection using a Skin-Glossymeter GL200 (Courage & Khazaka)
4 Months
Age-related changes in skin color on the cheek
Time Frame: 4 Months
Skin colorimetric measurement using a Spectrophotometer (Konica Minolta)
4 Months
Age-related changes in skin melanin on the cheek
Time Frame: 4 Months
Colorimetric measurement of skin melanin using a Mexameter MX18 (Courage & Khazaka)
4 Months
Age-related changes in skin elasticity on the cheek and thigh
Time Frame: 4 Months
Skin elasticity measurement using a Cutometer (Courage & Khazaka), ElastiMeter (Delfin Technologies), and Dermal Torque Meter (Dia-Stron Limited)
4 Months
Age-related changes in skin thickness on the cheek and thigh
Time Frame: 4 Months
Ultrasound imaging using a Dermascan Ultrasound (Cortex Technology)
4 Months
Age-related changes in skin topography on the cheek and thigh
Time Frame: 4 Months
Skin topography imaged using a PRIMOS (Canfield Scientific) fringe projection imaging system. Output measurements from the images will include Ra (average roughness), Rz (average height of roughness), and Rt (maximum height of the roughness profile).
4 Months
Age-related changes in skin topography on the cheek and thigh
Time Frame: 4 Months
Skin topography imaged using a DermaTOP (EOTECH) fringe projection imaging system. Output measurements from the images will include Ra (average roughness), Rz (average height of roughness), and Rt (maximum height of the roughness profile).
4 Months
Age-related changes in skin density on the cheek and thigh
Time Frame: 4 Months
Ultrasound imaging using a Dermascan Ultrasound (Cortex Technology)
4 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reproducibility and repeatability of the skin hydration measurement on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the tissue dielectric constant measurement using MoistureMeter D (Delfin Technologies) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the skin hydration measurement on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the tissue dielectric constant measurement using a Corneometer (Courage & Khazaka) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the skin barrier function measurement on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the Transepidermal water loss measurement using an AquaFlux AF100 (Biox Systems Ltd) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the skin radiance measurement on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the light reflection using a Skin-Glossymeter GL200 (Courage & Khazaka) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the skin color measurement on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the skin colorimetric measurement using a Spectrophotometer (Konica Minolta) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the skin melanin changes on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the colorimetric measurement of skin melanin using a Mexameter MX18 (Courage & Khazaka) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the changes in skin elasticity on the cheek and thigh
Time Frame: 4 Months
The reproducibility and repeatability of the skin elasticity measurement using a Cutometer (Courage & Khazaka), ElastiMeter (Delfin Technologies), and Dermal Torque Meter (Dia-Stron Limited) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the changes in skin thickness and density on the cheek and thigh
Time Frame: 4 Months
The reproducibility and repeatability of the measurement of ultrasound imaging using a Dermascan Ultrasound (Cortex Technology) will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the changes in skin topography on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the skin topographyusing a PRIMOS (Canfield Scientific) fringe projection imaging system will be determined by repeating the measurement three times by two technicians
4 Months
Reproducibility and repeatability of the changes in skin topography on the cheek
Time Frame: 4 Months
The reproducibility and repeatability of the skin topography will be imaged using a DermaTOP (EOTECH) fringe projection imaging system and will be determined by repeating the measurement three times by two technicians
4 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Siham Rharbaoui, MD, DERMSCAN - Pharmascan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2019

Primary Completion (Actual)

July 12, 2019

Study Completion (Actual)

July 12, 2019

Study Registration Dates

First Submitted

January 24, 2019

First Submitted That Met QC Criteria

February 13, 2019

First Posted (Actual)

February 15, 2019

Study Record Updates

Last Update Posted (Actual)

July 17, 2019

Last Update Submitted That Met QC Criteria

July 16, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2019-602-000

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-related Skin Changes

3
Subscribe